Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top
Stocks & Markets Analysis
Views 3.3M Contents 5432

$Moderna (MRNA.US)$$Walvax Biotechnology (300142.SZ)$ [AIDS ...

$Moderna (MRNA.US)$ $Walvax Biotechnology (300142.SZ)$
[AIDS vaccine enters human experimental stage]
▲Moderna AIDS vaccine will start human trials on August 19 and is expected to be completed in the spring of 2023, using mRNA technology similar to the new crown vaccine.
▲Moderna has two candidate HIV vaccines, mRNA-1644 and mRNA-1644v2-Core. These two vaccines have passed preliminary safety tests before they were first used in humans.
▲The new crown epidemic has accelerated the maturity of mRNA vaccine technology, and this technology is also a technology that can achieve mass production as soon as possible. Several other companies are also developing AIDS vaccines. Some candidate vaccines are currently or are about to enter clinical trials.

Looking forward to Watson's breakthroughs in other infectious diseases, just do international mRNA fast-follow.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
3
+0
4
Translate
Report
45K Views
Comment
Sign in to post a comment